Derma Sciences, Inc. (Derma Sciences) is a tissue regeneration company. The Company is focused on three segments of the wound care marketplace: advanced wound care, which provides Medihoney dressings, Bioguard, Xtrasorb, TCC-EZ, ALGICELL AG and DERMAGRAN products; traditional wound care, which offers branded gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices for the medical markets; and pharmaceutical wound care, which offers DSC127, an angiotensin analog. The Company markets its products principally through direct sales representatives in the United States, Canada and the United Kingdom, and through independent distributors within other international markets. The Company’s U.S. distribution facilities are located in St. Louis, Missouri and Houston, Texas. The Company has manufacturing facilities in Toronto, Canada and Nantong, China.